Quantum Biopharma Ltd. financial data

Symbol
QNTM on Nasdaq
Location
Toronto
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 28 Mar 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 72 shares

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense 745K USD +2158%
General And Administrative Expense 3.25M USD +5.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 17.1M USD -2.04%
Liabilities 6.68M USD +46.3%